Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Operating Expenses | 649 | 570 | 649 | 649 | 1,035 |
| Operating Income | -649 | -570 | -649 | -649 | -1,035 |
| Other Income | -406 | -10 | -48 | 8 | 13 |
| Pre-tax Income | -1,055 | -580 | -697 | -641 | -1,022 |
| Net Income Continuous | -1,055 | -580 | -697 | -641 | -1,022 |
| Net Income | $-1,055 | $-580 | $-697 | $-641 | $-1,022 |
| EPS Basic Total Ops | -0.03 | -0.02 | -0.02 | -0.02 | -0.03 |
| EPS Basic Continuous Ops | -0.03 | -0.02 | -0.02 | -0.02 | -0.03 |
| EPS Diluted Total Ops | -0.05 | -0.02 | -0.02 | -0.02 | -0.03 |
| EPS Diluted Continuous Ops | -0.03 | -0.02 | -0.02 | -0.02 | -0.03 |
| EBITDA(a) | $-649 | $-570 | $-649 | $-649 | $-1,035 |